| Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells H Pollard, JS Remy, G Loussouarn, S Demolombe, JP Behr, D Escande Journal of Biological Chemistry 273 (13), 7507-7511, 1998 | 931 | 1998 |
| Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability P Erbacher, S Zou, T Bettinger, AM Steffan, JS Remy Pharmaceutical research 15, 1332-1339, 1998 | 754 | 1998 |
| The magnetofection method: using magnetic force to enhance gene delivery C Plank, U Schillinger, F Scherer, C Bergemann, JS Rémy, F Krötz, ... Walter de Gruyter 384 (5), 737-747, 2003 | 630 | 2003 |
| Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system D Goula, JS Remy, P Erbacher, M Wasowicz, G Levi, B Abdallah, ... Gene therapy 5 (5), 712-717, 1998 | 450 | 1998 |
| A model for non‐viral gene delivery: Through syndecan adhesion molecules and powered by actin I Kopatz, JS Remy, JP Behr The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2004 | 415 | 2004 |
| Systemic linear polyethylenimine (L‐PEI)‐mediated gene delivery in the mouse SM Zou, P Erbacher, JS Remy, JP Behr The journal of gene medicine 2 (2), 128-134, 2000 | 408 | 2000 |
| Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses. JS Remy, A Kichler, V Mordvinov, F Schuber, JP Behr Proceedings of the National Academy of Sciences 92 (5), 1744-1748, 1995 | 390 | 1995 |
| Transfection and physical properties of various saccharide, poly (ethylene glycol), and antibody‐derivatized polyethylenimines (PEI) P Erbacher, T Bettinger, P Belguise‐Valladier, S Zou, JL Coll, JP Behr, ... The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 1999 | 387 | 1999 |
| Gene transfer with a series of lipophilic DNA-binding molecules JS Remy, C Sirlin, P Vierling, JP Behr Bioconjugate chemistry 5 (6), 647-654, 1994 | 370 | 1994 |
| Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway P Erbacher, JS Remy, JP Behr Gene therapy 6 (1), 138-145, 1999 | 349 | 1999 |
| Gene transfer with lipospermines and polyethylenimines JS Remy, B Abdallah, MA Zanta, O Boussif, JP Behr, B Demeneix Advanced Drug Delivery Reviews 30 (1-3), 85-95, 1998 | 346 | 1998 |
| Synthesis of giant globular multivalent glycofullerenes as potent inhibitors in a model of Ebola virus infection A Muñoz, D Sigwalt, BM Illescas, J Luczkowiak, L Rodriguez-Perez, ... Nature chemistry 8 (1), 50-57, 2016 | 307 | 2016 |
| Monomolecular collapse of plasmid DNA into stable virus-like particles T Blessing, JS Remy, JP Behr Proceedings of the National Academy of Sciences 95 (4), 1427-1431, 1998 | 291 | 1998 |
| Proton sponge trick for pH-sensitive disassembly of polyethylenimine-based siRNA delivery systems G Creusat, AS Rinaldi, E Weiss, R Elbaghdadi, JS Remy, R Mulherkar, ... Bioconjugate chemistry 21 (5), 994-1002, 2010 | 244 | 2010 |
| Dimerizable cationic detergents with a low cmc condense plasmid DNA into nanometric particles and transfect cells in culture E Dauty, JS Remy, T Blessing, JP Behr Journal of the American Chemical Society 123 (38), 9227-9234, 2001 | 243 | 2001 |
| Size reduction of galactosylated PEI/DNA complexes improves lectin-mediated gene transfer into hepatocytes T Bettinger, JS Remy, P Erbacher Bioconjugate chemistry 10 (4), 558-561, 1999 | 229 | 1999 |
| Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery D Finsinger, JS Remy, P Erbacher, C Koch, C Plank Gene therapy 7 (14), 1183-1192, 2000 | 212 | 2000 |
| Intracellular delivery of nanometric DNA particles via the folate receptor E Dauty, JS Remy, G Zuber, JP Behr Bioconjugate chemistry 13 (4), 831-839, 2002 | 161 | 2002 |
| Gene transfer optimization with lipospermine-coated DNA F Barthel, JS Remy, JP Loeffler, JP Behr DNA and cell biology 12 (6), 553-560, 1993 | 137 | 1993 |
| The p21cip1/waf1 cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells H Lincet, L Poulain, JS Remy, E Deslandes, F Duigou, P Gauduchon, ... Cancer letters 161 (1), 17-26, 2000 | 128 | 2000 |
jean paul behrAcademie des Sciences在 academie-sciences.fr 的电子邮件经过验证
